BACKGROUND: Dendritic cells (DC) play an important role in the induction and regulation of immune responses. METHODS: Myeloid CD11c+ DC (MDC), which may have inflammatory functions, and plasmacytoid CD123+ DC (PDC), which may have tolerogenic potential, were measured by flow cytometric analysis, cross-sectionally, once, in 48 children, and longitudinally (pretransplant and at days 1-60, 61-200, and 201-400 posttransplant) in 30 children after liver transplantation (LTx). All children received cadaveric (n=53) or live donor (n=25) liver allografts with rabbit anti-human thymocyte globulin induction and steroid-free tacrolimus therapy. Rejectors in both groups were those children (n=35), who experienced biopsy-proven acute cellular rejection (ACR) within 60 days of DC monitoring. RESULTS: Among rejectors in the longitudinal and cross-sectional cohorts, the MDC:PDC ratio was higher and was associated with decreased PDC frequencies. Logistic regression analysis, leave-one-out cross-validation, and receiver operating characteristic analysis applied to 30 cross-sectional subjects revealed that an MDC:PDC ratio more than or equal to 1.78 was associated with rejector status with sensitivity and specificity of 76.9% and 88.2%, respectively. Sensitivity and specificity were replicated in the 18 remaining cross-sectional subjects (88.8% and 78.8%, respectively), but not in longitudinally monitored subjects, during the early 60-day period after LTx (30.76% and 62.50%, respectively). A significant negative correlation was observed between tacrolimus whole blood concentrations and PDC frequencies (Spearman r=-0.370, P=0.005) in 48 cross-sectional subjects in whom DC subsets were monitored 1 to 3 years after LTx, but not during the early post-LTx period. CONCLUSIONS: We conclude that an elevated MDC:PDC ratio associates with liver graft rejection, which occurs after first year in children induced with rabbit anti-human thymocyte globulin.
BACKGROUND: Dendritic cells (DC) play an important role in the induction and regulation of immune responses. METHODS: Myeloid CD11c+ DC (MDC), which may have inflammatory functions, and plasmacytoid CD123+ DC (PDC), which may have tolerogenic potential, were measured by flow cytometric analysis, cross-sectionally, once, in 48 children, and longitudinally (pretransplant and at days 1-60, 61-200, and 201-400 posttransplant) in 30 children after liver transplantation (LTx). All children received cadaveric (n=53) or live donor (n=25) liver allografts with rabbit anti-human thymocyte globulin induction and steroid-free tacrolimus therapy. Rejectors in both groups were those children (n=35), who experienced biopsy-proven acute cellular rejection (ACR) within 60 days of DC monitoring. RESULTS: Among rejectors in the longitudinal and cross-sectional cohorts, the MDC:PDC ratio was higher and was associated with decreased PDC frequencies. Logistic regression analysis, leave-one-out cross-validation, and receiver operating characteristic analysis applied to 30 cross-sectional subjects revealed that an MDC:PDC ratio more than or equal to 1.78 was associated with rejector status with sensitivity and specificity of 76.9% and 88.2%, respectively. Sensitivity and specificity were replicated in the 18 remaining cross-sectional subjects (88.8% and 78.8%, respectively), but not in longitudinally monitored subjects, during the early 60-day period after LTx (30.76% and 62.50%, respectively). A significant negative correlation was observed between tacrolimus whole blood concentrations and PDC frequencies (Spearman r=-0.370, P=0.005) in 48 cross-sectional subjects in whom DC subsets were monitored 1 to 3 years after LTx, but not during the early post-LTx period. CONCLUSIONS: We conclude that an elevated MDC:PDC ratio associates with liver graft rejection, which occurs after first year in children induced with rabbit anti-human thymocyte globulin.
Authors: S John Swanson; Douglas A Hale; Roslyn B Mannon; David E Kleiner; Linda C Cendales; Christine E Chamberlain; Shirley M Polly; David M Harlan; Allan D Kirk Journal: Lancet Date: 2002-11-23 Impact factor: 79.321
Authors: Annika C Karlsson; Jeffrey N Martin; Sophie R Younger; Barry M Bredt; Lorrie Epling; Rollie Ronquillo; Arjun Varma; Steven G Deeks; Joseph M McCune; Douglas F Nixon; Elizabeth Sinclair Journal: J Immunol Methods Date: 2003-12 Impact factor: 2.303
Authors: Thomas E Starzl; Noriko Murase; Kareem Abu-Elmagd; Edward A Gray; Ron Shapiro; Bijan Eghtesad; Robert J Corry; Mark L Jordan; Paulo Fontes; Tim Gayowski; Geoffrey Bond; Velma P Scantlebury; Santosh Potdar; Parmjeet Randhawa; Tong Wu; Adriana Zeevi; Michael A Nalesnik; Jennifer Woodward; Amadeo Marcos; Massimo Trucco; Anthony J Demetris; John J Fung Journal: Lancet Date: 2003-05-03 Impact factor: 79.321
Authors: George V Mazariegos; Alan F Zahorchak; Jorge Reyes; Lynn Ostrowski; Bridget Flynn; Adriana Zeevi; Angus W Thomson Journal: Am J Transplant Date: 2003-06 Impact factor: 8.086
Authors: Jonathan A Fridell; Ashok Jain; Jorge Reyes; Rebecca Biederman; Michael Green; Rakesh Sindhi; George V Mazariegos Journal: Transplantation Date: 2002-12-27 Impact factor: 4.939
Authors: Shao Zonghong; Tu Meifeng; Wang Huaquan; Xing Limin; Wang Jun; Fu Rong; Liu Hong; Wu Yuhong Journal: Int J Hematol Date: 2011-01-14 Impact factor: 2.490
Authors: Tim Chan; Timothy C Back; Jeffrey J Subleski; Jonathan M Weiss; John R Ortaldo; Robert H Wiltrout Journal: PLoS One Date: 2012-03-13 Impact factor: 3.240
Authors: Jian Fu; Christian H K Lehmann; Xinning Wang; Mandy Wahlbuhl; Ida Allabauer; Benjamin Wilde; Lukas Amon; Sebastian Dolff; Robert Cesnjevar; Andreas Kribben; Joachim Woelfle; Wolfgang Rascher; Peter F Hoyer; Diana Dudziak; Oliver Witzke; André Hoerning Journal: Sci Rep Date: 2021-12-10 Impact factor: 4.379
Authors: Alberto Baroja-Mazo; Beatriz Revilla-Nuin; Pascual Parrilla; Laura Martínez-Alarcón; Pablo Ramírez; José Antonio Pons Journal: World J Gastroenterol Date: 2016-09-14 Impact factor: 5.742
Authors: Antonino Castellaneta; Antonio Massaro; Maria Rendina; Francesca D'Errico; Sonia Carparelli; Salvatore Fabio Rizzi; Angus W Thomson; Alfredo Di Leo Journal: Transplant Res Date: 2016-01-20